Cargando…
Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo
Triple-negative breast cancers are associated with poor clinical outcomes and new therapeutic strategies are clearly needed. Gallotannin (Gltn) has been previously demonstrated to have potent anti-tumor properties against cholangiocarcinoma in mice, but little is known regarding its capacity to supp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962455/ https://www.ncbi.nlm.nih.gov/pubmed/24658335 http://dx.doi.org/10.1371/journal.pone.0092853 |
_version_ | 1782308441289654272 |
---|---|
author | Zhao, Tiejun Sun, Qiang del Rincon, Sonia V. Lovato, Amanda Marques, Maud Witcher, Michael |
author_facet | Zhao, Tiejun Sun, Qiang del Rincon, Sonia V. Lovato, Amanda Marques, Maud Witcher, Michael |
author_sort | Zhao, Tiejun |
collection | PubMed |
description | Triple-negative breast cancers are associated with poor clinical outcomes and new therapeutic strategies are clearly needed. Gallotannin (Gltn) has been previously demonstrated to have potent anti-tumor properties against cholangiocarcinoma in mice, but little is known regarding its capacity to suppress tumor outgrowth in breast cancer models. We tested Gltn for potential growth inhibitory properties against a variety of breast cancer cell lines in vitro. In particular, triple-negative breast cancer cells display higher levels of sensitivity to Gltn. The loss of proliferative capacity in Gltn exposed cells is associated with slowed cell cycle progression and S phase arrest, dependent on Chk2 phosphorylation and further characterized by changes to proliferation related genes, such as cyclin D1 (CcnD1) as determined by Nanostring technology. Importantly, Gltn administered orally or via intraperitoneal (IP) injections greatly reduced tumor outgrowth of triple-negative breast cells from mammary fat pads without signs of toxicity. In conclusion, these data strongly suggest that Gltn represents a novel approach to treat triple-negative breast carcinomas. |
format | Online Article Text |
id | pubmed-3962455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39624552014-03-24 Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo Zhao, Tiejun Sun, Qiang del Rincon, Sonia V. Lovato, Amanda Marques, Maud Witcher, Michael PLoS One Research Article Triple-negative breast cancers are associated with poor clinical outcomes and new therapeutic strategies are clearly needed. Gallotannin (Gltn) has been previously demonstrated to have potent anti-tumor properties against cholangiocarcinoma in mice, but little is known regarding its capacity to suppress tumor outgrowth in breast cancer models. We tested Gltn for potential growth inhibitory properties against a variety of breast cancer cell lines in vitro. In particular, triple-negative breast cancer cells display higher levels of sensitivity to Gltn. The loss of proliferative capacity in Gltn exposed cells is associated with slowed cell cycle progression and S phase arrest, dependent on Chk2 phosphorylation and further characterized by changes to proliferation related genes, such as cyclin D1 (CcnD1) as determined by Nanostring technology. Importantly, Gltn administered orally or via intraperitoneal (IP) injections greatly reduced tumor outgrowth of triple-negative breast cells from mammary fat pads without signs of toxicity. In conclusion, these data strongly suggest that Gltn represents a novel approach to treat triple-negative breast carcinomas. Public Library of Science 2014-03-21 /pmc/articles/PMC3962455/ /pubmed/24658335 http://dx.doi.org/10.1371/journal.pone.0092853 Text en © 2014 Zhao et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Zhao, Tiejun Sun, Qiang del Rincon, Sonia V. Lovato, Amanda Marques, Maud Witcher, Michael Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo |
title | Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo
|
title_full | Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo
|
title_fullStr | Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo
|
title_full_unstemmed | Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo
|
title_short | Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo
|
title_sort | gallotannin imposes s phase arrest in breast cancer cells and suppresses the growth of triple-negative tumors in vivo |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962455/ https://www.ncbi.nlm.nih.gov/pubmed/24658335 http://dx.doi.org/10.1371/journal.pone.0092853 |
work_keys_str_mv | AT zhaotiejun gallotanninimposessphasearrestinbreastcancercellsandsuppressesthegrowthoftriplenegativetumorsinvivo AT sunqiang gallotanninimposessphasearrestinbreastcancercellsandsuppressesthegrowthoftriplenegativetumorsinvivo AT delrinconsoniav gallotanninimposessphasearrestinbreastcancercellsandsuppressesthegrowthoftriplenegativetumorsinvivo AT lovatoamanda gallotanninimposessphasearrestinbreastcancercellsandsuppressesthegrowthoftriplenegativetumorsinvivo AT marquesmaud gallotanninimposessphasearrestinbreastcancercellsandsuppressesthegrowthoftriplenegativetumorsinvivo AT witchermichael gallotanninimposessphasearrestinbreastcancercellsandsuppressesthegrowthoftriplenegativetumorsinvivo |